We are live on
!
Find out more
CCM
Cloverdale Capital Management Portfolio holdings
AUM
$135M
1-Year Est. Return
13.89%
This Fund
S&P 500
This Quarter
Est. Return
+14.51%
1 Year Est. Return
-13.89%
3 Year Est. Return
+20.77%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$125M
AUM Growth
–
Cap. Flow
+$116M
Cap. Flow
% of AUM
92.93%
Top 10 Holdings %
Top 10 Hldgs %
85.37%
Holding
18
New
18
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Barrett Business Services
BBSI
|
+$12M |
| 2 |
Bio-Rad Laboratories Class A
BIO
|
+$11.9M |
| 3 |
Take-Two Interactive
TTWO
|
+$11.6M |
| 4 |
MSGN
MSG Networks Inc.
MSGN
|
+$11.6M |
| 5 |
LiveRamp
RAMP
|
+$11.1M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 21.1% |
| 2 | Communication Services | 19.71% |
| 3 | Industrials | 17.9% |
| 4 | Technology | 15.56% |
| 5 | Consumer Discretionary | 5% |
Similar funds
BWM
CCM
LM
SCM
GTP
JT
BC
LI
Cloverdale Capital Management's Q4 2016 Portfolio in Review
Q4 2016 is the first quarter with a 13F filing on record for Cloverdale Capital Management, which disclosed 18 positions worth $125M. Its ten largest holdings account for 85% of the portfolio.
Its largest position is Barrett Business Services: 890,788 shares worth $14.3M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, followed by Communication Services and Industrials.
- Cloverdale Capital Management's largest Q4 2016 buy was Barrett Business Services: 890,788 shares worth $14.3M.
- Cloverdale Capital Management's ten largest holdings make up 85% of its $125M portfolio in Q4 2016.
- Cloverdale Capital Management disclosed 18 positions in Q4 2016, its first 13F filing on record.
Based on Cloverdale Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.